PDF(867 KB)
Medication of postpartum hemorrhage
FU Chen-wei, LIU Jun-tao
Chinese Journal of Practical Gynecology and Obstetrics ›› 2014, Vol. 30 ›› Issue (4) : 262-265.
PDF(867 KB)
PDF(867 KB)
Medication of postpartum hemorrhage
Abstract:Postpartum hemorrhage (PPH) is the leading cause of maternal mortality. The four Ts of PPH are Tone, Trauma, Tissue and Thrombin. Etiological treatment is the essential treatment. Uterotonic therapy is the most important medication of postpartum hemorrhage. The successful management of uterine atony will depend on the proper usage of the tocolytic agents, such as oxytocin, carboprost and misoprostol. Uterine packing and uterine artery embolism might be useful if the usage of tocolytic agents is not effective.
[1］ 丰有吉，沈铿.妇产科学（供7年制及8年制临床医学生用）［M］.2版.北京：人民卫生出版社，2010：113-119.
[2］ WHO.WHO guidelines for the management of postpartum haemorrhage and retained placenta (issued 2009).
[3］ Su LL, Chong YS, Samuel M. Oxytocin agonists for preventing postpartum hemorrhage [J]. Cochrane Database Syst Rev, 2007,18(3):CD005457.
[4］ Blum J, Winikoff B, Raghavan S, et al. Treatment of post-hemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin:a double-blind, randomized, non-inferiority trial [J]. Lancet, 2010, 375:217-223.
[5］ Winikoff B, Dabash R, Durocher J, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour:a double-blind, randomized, non-inferiority trial [J]. Lancet, 2010,375:210-216.
[6］ Widmer M, Blum J, Hofmeyr GJ, et al. Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage:a multicentre, double-blind randomized trial [J]. Lancet, 2010,75:1808-1813.
[7］ Hofmeyr GJ, Walraven G, Gulmezoglu AM, et al. Misoprostol to treat postpartum haemorrhage:a systematic review [J]. BJOG, 2005, 112:547-553.
[8］ Tang J, Kapp N, Dragoman M,et al. WHO recommendations for misoprostol use for obstetric and gynecologic indications [J]. Int J Gynaecol Obstet, 2013, 121:186-189.
[9］ Lamont RF, Morgan DJ, Logue M, et al. A prospective randomized trial to compare the efficacy and safty of hemabate and syntometrine for the prevention of primary postpartum haemorrhage [J]. Prostalandins Other Lipid Mediat, 2001, 66(3):203-210.
[10］ Price G, Kaplan J,Skowronski G. Use of recombinant factor Ⅶa to treat life-threatening non-surgical bleeding in a post-partum patient [J]. Br J Anaesth, 2004,93:298-300.
/
| 〈 |
|
〉 |
